unknown
Stage
1
Investors
About
eNLife Research develops biomarker-based early detection methods and nano-scale precision therapeutics for neurodegenerative diseases, primarily focusing on Alzheimer's Disease.
Explore eNLife Research's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.